Join
Live feed
·
INSIDERFilingvia Quantisnow
X4 Pharmaceuticals Inc. logo

Chief Operating Officer Dibiase Mary sold $1,738 worth of shares (2,642 units at $0.66), decreasing direct ownership by 0.91% to 289,110 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
XFOR· X4 Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XFOR (X4 Pharmaceuticals Inc.) and more on Quantisnow.